A prospective randomized evaluator-blinded trial of two potential wound healing agents for the treatment of venous stasis ulcers
Bishop JB, Phillips LG, Mustoe TA, et al. Journal of Vascular Surgery 1992;16:251-257.
What it found
Silver sulfadiazine 1% cream reduced ulcer size more than placebo. The tripeptide copper cream did no better than placebo.
Limitations
The abstract describes the product only as a biologically active tripeptide copper complex and does not name it as GHK-Cu. Topical use only. Negative result for the copper cream.
Research and education only. Not medical advice. Many peptides on this site are not approved by the FDA for human use. Doses shown are the ones used in published studies and are not a recommendation. Talk to a licensed clinician before using any of them. Read the full disclaimer.